# Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)

Study · id `cardio:ct-nct04624854` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04624854](<https://clinicaltrials.gov/study/NCT04624854>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04624854

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 8250 participants.

## Technical summary

Registry record NCT04624854. Randomized; no masking; primary purpose treatment. Start 2020-10-28 (actual); primary completion 2025-09-23 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 8250 participants (enrolled count; ClinicalTrials.gov record NCT04624854, source copy `cardio:ctgov-nct04624854-2025-12-01`, retrieved 2026-10-26)
- Started: 2020-10-28 (actual) (ClinicalTrials.gov record NCT04624854, source copy `cardio:ctgov-nct04624854-2025-12-01`, retrieved 2026-10-26)
- Primary completion: 2025-09-23 (actual) (ClinicalTrials.gov record NCT04624854, source copy `cardio:ctgov-nct04624854-2025-12-01`, retrieved 2026-10-26)
- Completion: 2025-09-23 (actual) (ClinicalTrials.gov record NCT04624854, source copy `cardio:ctgov-nct04624854-2025-12-01`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04624854, source copy `cardio:ctgov-nct04624854-2025-12-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04624854-2025-12-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)
- Condition: Coronary Artery Disease
- Condition: Myocardial Ischemia
- Condition: Acute Coronary Syndrome
- Condition: Heart Diseases
- Condition: Syndrome Heart Disease
- Condition: Cardiovascular Diseases
- Condition: Arteriosclerosis
- Condition: Arterial Occlusive Diseases
- Condition: Coronary Disease
- Condition: Vascular Diseases
- Intervention (Drug): Clopidogrel and aspirin dual-antiplatelet therapy
- Intervention (Drug): Aspirin monotherapy
- Lead sponsor: Harbin Medical University
- Lead sponsor class: OTHER
- Collaborator: Chinese Society of Cardiology
- Collaborator class: OTHER
- Collaborator: Lepu Medical Technology (Beijing) Co., Ltd.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Harbin Medical University (`cardio:org-harbin-medical-university`)
- Registry lists this organization as a collaborator: Chinese Society of Cardiology (`cardio:org-chinese-society-of-cardiology`)
- Registry lists this organization as a collaborator: Lepu Medical Technology (Beijing) Co., Ltd. (`cardio:org-lepu-medical-technology-beijing-co-ltd`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Extended Dual Antiplatelet Therapy for Multivessel Coronary Artery Disease (`cardio:pubmed-42456136`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 898f793ae4a9c56177d7f30ef1599699cf083068ab9421afd08e112ed850cf5b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
